BENGALURU - Indian shares rose on Tuesday after a bruising coronavirus-led decline in the last session, as beaten-down banking stocks gained and drug companies climbed due to a vaccine approval.
The NSE Nifty 50 index was up 0.36% at 14,363.20, while the S&P BSE Sensex was 0.35% higher at 48,052.45. Each index fell more than 3% on Monday, making it their second worst day in 2021.
Indian regulatory approval for Russia's Sputnik V COVID-19 vaccine sent shares in local partner Dr Reddy's Labs up as much as 3%. Cipla and Sun Pharma, which sell COVID-19 medication, continued to gain amid a surge in domestic infections.
State-run banks gained 2.4% and were among the top sectoral gainers. The index had dropped 9% in the previous session.
IT services consultancy TCS fell more than 3% after its March-quarter profit missed analysts' estimates.
Meanwhile, India's retail inflation accelerated to a four-month high in March on higher food and transport costs, data showed on Monday.
(Reporting by Sachin Ravikumar in Bengaluru; editing by Uttaresh.V) ((email@example.com; +91 80 6182 2754; Twitter: @sachinr27;))